These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8270900)

  • 21. Prevalence of hypercholesterolemia among siblings of persons with premature coronary heart disease. Application of the Second Adult Treatment Panel guidelines.
    Allen JK; Young DR; Blumenthal RS; Moy TF; Yanek LR; Wilder L; Becker LC; Becker DM
    Arch Intern Med; 1996 Aug 12-26; 156(15):1654-60. PubMed ID: 8694663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Cholesterol Education Program: highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. US Department of Health and Human Services, Public Health Service. National Institutes of Health, National Heart, Lung, and BloodInstitute.
    J Am Osteopath Assoc; 1992 Mar; 92(3):380-8. PubMed ID: 1592663
    [No Abstract]   [Full Text] [Related]  

  • 23. Pediatric cholesterol screening: missed opportunities.
    Liacouras CA; Shamir R
    Isr J Med Sci; 1997 Oct; 33(10):659-62. PubMed ID: 9397139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A practical approach to dietary therapy for patients with high blood cholesterol levels. Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, National Cholesterol Education Program.
    Md Med J; 1988 Apr; 37(4):258-61. PubMed ID: 3367715
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypercholesterolemia in children: risk and management.
    Mistretta EF; Stroud S
    Pediatr Nurs; 1990; 16(2):152-4. PubMed ID: 2359640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypolipemic agents and prevention of coronary disease].
    Chadarevian R; Bruckert E; Turpin G
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):89-98. PubMed ID: 9137675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National Cholesterol Education Program, second report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults.
    Rubinstein A
    Circulation; 1995 Feb; 91(3):908-9. PubMed ID: 7828323
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ
    Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How concerned are elderly patients without coronary heart disease about hypercholesterolemia and heart disease? An UPRNet study. Upper Peninsula Research Network.
    Reddy E; Kreher N; Hickner JM
    J Fam Pract; 1998 Mar; 46(3):227-32. PubMed ID: 9519020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated blood cholesterol. A risk factor for coronary heart disease.
    LaRosa JH; Becker DM; Fitzgerald S
    AAOHN J; 1990 May; 38(5):211-5. PubMed ID: 2331249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Screening for risk factors in agricultural schools of 5 Austrian federal counties ].
    Yang Q; Fischer W; Virgolini I; Seyfried H; Widhalm K; Sinzinger H
    Wien Med Wochenschr; 1993; 143(6):134-41. PubMed ID: 8517064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hypercholesterolemia in childhood and adolescence.
    Kronn DF; Sapru A; Satou GM
    Heart Dis; 2000; 2(5):348-53. PubMed ID: 11728281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New guidelines from the National Cholesterol Education Program: what is the impact on risk assessment?
    Lowden JA
    J Insur Med; 2002; 34(1):26-30. PubMed ID: 15303591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Broader indication for treatment with statins; the 'heart protection study'].
    Stalenhoef AF; Stuyt PM
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1921-3. PubMed ID: 12404905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current developments in prevention of coronary heart disease].
    Windler E
    Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.